American Association for Cancer Research

Colorectal Cancer: Molecular Pathways and Therapies

October 19 - 23, 2005
Laguna Cliffs Marriott Resort and Spa
Dana Point, California

CONFERENCE CHAIRPERSONS
Raymond N. DuBois, Vanderbilt-Ingram Cancer Center, Nashville, TN
Stanley R. Hamilton, UT M. D. Anderson Cancer Center, Houston, TX
Raju Kucherlapati, Harvard Medical School, Boston, MA

The major objective of this conference was to provide an overview of the cutting-edge scientific knowledge on the gene pathways, drug development, treatment, and epidemiology of colorectal cancer. Specifically, the conference objectives were to bring together colorectal cancer scientists from around the world to engage in an intensive intellectual exchange of the status of this area of investigation and how new methodologies, approaches, and thinking can hasten the development of effective therapies for this cancer.

It was also important to the conference chairpersons to bring young scientists together, broaden their horizons, and provide new ideas that would be important in their own research and career development. Our knowledge of colorectal cancer is rapidly increasing and has seen significant growth during the past ten or more years. This has been fueled by initial genetic approaches to identify genes involved in the initiation of colorectal cancer. Following these discoveries, our knowledge is being driven by biological, biochemical, and genomic approaches. Focused conferences such as this one have the potential to unite the scientific community to the common goal of understanding the molecular etiology of colorectal cancer and to mobilize this group to important discoveries that are necessary for early detection and treatment of this important cancer.

Researchers and scientists from nearly 20 different countries participated in the 2005 AACR Special Conference on Colorectal Cancer. Plenary sessions focused on the latest discoveries in treatment and predictive markers, DNA repair and mouse models, pathways and mechanisms of metastatic spread, clinical approaches, epidemiology and prevention, and emerging technologies.

Please visit the AACR Meeting Calendar for a complete list of upcoming programs.

*(Adobe Acrobat Reader required)